
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Cheshire 3009788676810.1007/s12325-018-0768-zCorrectionCorrection to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars Rezk Mourad F. mouradfarouk.rezk@biogen.com Pieper Burkhard Biogen International GmbH, Zug, Switzerland 10 8 2018 10 8 2018 2018 35 9 1470 1470 © The Author(s) 2018issue-copyright-statement© Springer Healthcare Ltd., part of Springer Nature 2018
==== Body
Correction to: Adv Ther (2018) 35:749–753 10.1007/s12325-018-0719-8
The article “To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars”, written by Mourad F. Rezk and Burkhard Pieper was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 5, 2018 without open access.

The copyright of the article changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and Indicate if changes were made.

The original article has been corrected.

Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

